Furthermore, as was recently demonstrated on the rabbit model of atherosclerosis, oral supplementation of resveratrol has anti-inflammatory and anti-atherosclerotic effects, decreases serum levels of VEGF and CRP, and reduces atherosclerotic lesions’ formation and development [86]. Here, VEGFA is linked to atherosclerosis.